Dunkin Brands Group (NASDAQ:DNKN) CEO Nigel Travis unloaded 18,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $50.65, for a total transaction of $911,700.00. Following the transaction, the chief executive officer now directly owns 274,377 shares of the company’s stock, valued at approximately $13,897,195. Dunkin Brands Group Inc (NASDAQ:DNKN) shares after opening at $48.02 moved to $48.10 on last trade day and at the end of the day closed at $46.92. Company price to sales ratio in past twelve months was calculated as 7.01 and price to cash ratio as 19.47. Dunkin Brands Group Inc (NASDAQ:DNKN) showed a negative weekly performance of -6.50%.
The common stock of Hawaiian Electric Industries, Inc. (NYSE:HE) has been subject to abnormal trading volumes and substantial selling, apparently based on the release of a research report that contained multiple inaccuracies and made assertions about the potential need for the company to cut its dividend. Hawaiian Electric Industries, Inc. (NYSE:HE) shares fell -1.76% in last trading session and ended the day on $24.05. HE return on equity ratio is recorded as 9.80% and its return on assets is 1.60%. Hawaiian Electric Industries, Inc. (NYSE:HE) yearly performance is -8.90%.
Money that had flooded into biotech ETFs is bolting out now. On Friday alone, $372 million poured out of the market’s largest biotech ETF, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB), the biggest one-day outflow ever for the fund, according to BlackRock. The recent reversal comes after months of inflows. Some $8.4 billion piled into health-care and biotech ETFs from the start of 2013 through March, according to fund tracker Lipper, compared with about $8.9 billion absorbed by traditional mutual funds. iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) shares moved up 0.67% in last trading session and was closed at $226.82, while trading in range of $222.25-$231.08. iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) year to date performance is -0.11%.
CapitalSource (NYSE:CSE) CEO James Pieczynski unloaded 375,000 shares of the stock on the open market in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $14.55, for a total transaction of $5,456,250.00. Following the completion of the sale, the chief executive officer now directly owns 394,762 shares in the company, valued at approximately $5,743,787.CapitalSource, Inc. (NYSE:CSE) weekly performance is 6.24%. On last trading day company shares ended up $15.50. CapitalSource, Inc. (NYSE:CSE) distance from 50-day simple moving average is 7.88%. Analysts mean target price for the company is $13.36.